Benzinga | Mar 1, 2021 04:22PM EST

Aziyo Biologics Q4 EPS $(0.57) Misses $(0.50) Estimate, Sales $12.47M Beat $11.64M Estimate

Aziyo Biologics (NASDAQ:AZYO) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.50) by 14 percent. The company reported quarterly sales of $12.47 million which beat the analyst consensus estimate of $11.64 million by 7.10 percent.